Glucagon-like peptide-1 signifies a significant breakthrough in our management landscape . Originally developed to treat type 2 diabetes , these medications have revealed considerable ability to assist with fat loss and aid body well-being . Researchers increasingly investigating the impact in managing excess weight among individuals lacking a dia